H&F Corporate Investors X, Ltd. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001901930
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 1 positions · Total reported value $4.18B · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2025 13F filing, H&F Corporate Investors X, Ltd. disclosed 1 equity positions with a combined reported value of $4.18B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / Buy & Hold.
The largest disclosed positions as of Q4 2025 were MDLN ($4.18B). By sector, the heaviest allocations are Health Care 100.0%. Versus the prior quarter, allocation shifted toward Health Care (+100.0pp) and away from Other (-100.0pp).
Versus the prior quarter, H&F Corporate Investors X, Ltd. opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 0% of names.
The largest new positions opened in Q4 2025 were MDLN ($4.18B).
Of the 1 positions fully exited versus the prior quarter, the largest were SPLK ($1.95B).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- MDLN MEDLINE INC · $4.18B
Fully Exited (vs previous quarter)
- SPLK SPLUNK INC · prev qtr: $1.95B
Insider Transactions (Form 4)
Latest H&F Corporate Investors X, Ltd. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-05-28 | J | Medline Inc. | 141,364 | — | SEC filing |
| 2026-05-28 | J | Medline Inc. | 1,536,907 | — | SEC filing |
| 2026-05-28 | J | Medline Inc. | 209,530 | — | SEC filing |
| 2026-05-28 | Sell | Medline Inc. | 1,262,726 | $36.54 | SEC filing |
| 2026-05-28 | Sell | Medline Inc. | 11,904,646 | $36.54 | SEC filing |
| 2026-05-28 | Sell | Medline Inc. | 753,528 | $36.54 | SEC filing |
| 2026-05-28 | Sell | Medline Inc. | 17,947,337 | $36.54 | SEC filing |
| 2026-05-21 | J | Medline Inc. | 18,156,867 | — | SEC filing |
Fund Profile
H&F Corporate Investors X, Ltd. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 1 positions worth $2.80B in total. HoldingsHub carries 5 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 1 positions · $2.80B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MDLN (MEDLINE INC) at 100.0%
- Average position size: $2.80B
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 reduced
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
FAQ
What did H&F Corporate Investors X, Ltd. buy in 2025-Q4?
In its 2025-Q4 13F filing, H&F Corporate Investors X, Ltd. reported 1 equity positions worth $4.18B in aggregate; its largest disclosed positions were MDLN ($4.18B).
How large is H&F Corporate Investors X, Ltd.'s portfolio?
H&F Corporate Investors X, Ltd. reported $4.18B of long equity holdings across 1 positions as of 2025-Q4. Top-10 holdings account for 100.0% of reported value.
What is H&F Corporate Investors X, Ltd.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.